Roche Holding Ltd. (VTX:ROG) has been given a CHF 275 target price by equities research analysts at Jefferies Group LLC in a report released on Wednesday. The firm presently has a “buy” rating on the healthcare company’s stock.

Other research analysts have also issued reports about the company. Goldman Sachs Group, Inc. (The) set a CHF 335 price target on Roche Holding and gave the stock a “buy” rating in a research report on Saturday, May 20th. J P Morgan Chase & Co restated a “buy” rating on shares of Roche Holding in a research report on Wednesday, June 7th. Deutsche Bank AG set a CHF 260 price target on Roche Holding and gave the stock a “neutral” rating in a research report on Friday, July 7th. HSBC Holdings plc set a CHF 215 price target on Roche Holding and gave the stock a “sell” rating in a research report on Tuesday. Finally, Morgan Stanley set a CHF 290 price target on Roche Holding and gave the stock a “buy” rating in a research report on Tuesday. One analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of CHF 272.

Shares of Roche Holding (ROG) opened at 240.50 on Wednesday. The stock’s 50 day moving average price is CHK 259.00 and its 200 day moving average price is CHK 249.75. The stock has a market capitalization of CHK 204.90 billion and a P/E ratio of 20.64. Roche Holding has a one year low of CHK 218.30 and a one year high of CHK 273.00.

ILLEGAL ACTIVITY NOTICE: This report was reported by American Banking News and is the property of of American Banking News. If you are reading this report on another website, it was illegally stolen and republished in violation of U.S. & international copyright law. The correct version of this report can be read at https://www.americanbankingnews.com/2017/07/12/roche-holding-ltd-rog-given-a-chf-275-price-target-by-jefferies-group-llc-analysts.html.

Roche Holding Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (VTX:ROG)

Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.